HIGHLIGHTS
- who: Feifei Shen from the United States University of Illinois at Chicago have published the research work: Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer, in the Journal: (JOURNAL)
- what: In this study, the cutoff values were determined using the normal ranges, while previous studies used statistical methods to determine the cutoff.
- how: Multivariate analysis was performed using a stepwise forward Cox regression (likelihood ratio enter P and amplt 0.05 remove P > 0.10) with significant markers from the univariate analyses . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.